99 related articles for article (PubMed ID: 8396647)
1. A cluster of strong topoisomerase II cleavage sites is located near an integrated human immunodeficiency virus.
Howard MT; Griffith JD
J Mol Biol; 1993 Aug; 232(4):1060-8. PubMed ID: 8396647
[TBL] [Abstract][Full Text] [Related]
2. Identification of human cytomegalovirus target sequences in the human immunodeficiency virus long terminal repeat. Potential role of IE2-86 binding to sequences between -120 and -20 in promoter transactivation.
Yurochko AD; Huong SM; Huang ES
J Hum Virol; 1999; 2(2):81-90. PubMed ID: 10225210
[TBL] [Abstract][Full Text] [Related]
3. Quantitative in vitro assay for human immunodeficiency virus deoxyribonucleic acid integration.
Carteau S; Mouscadet JF; Goulaouic H; Subra F; Auclair C
Arch Biochem Biophys; 1993 Feb; 300(2):756-60. PubMed ID: 8434953
[TBL] [Abstract][Full Text] [Related]
4. In vitro analysis of human immunodeficiency virus type 1 minus-strand strong-stop DNA synthesis and genomic RNA processing.
Driscoll MD; Golinelli MP; Hughes SH
J Virol; 2001 Jan; 75(2):672-86. PubMed ID: 11134281
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of the polyanionic drug suramin on the in vitro HIV DNA integration reaction.
Carteau S; Mouscadet JF; Goulaouic H; Subra F; Auclair C
Arch Biochem Biophys; 1993 Sep; 305(2):606-10. PubMed ID: 8373200
[TBL] [Abstract][Full Text] [Related]
6. HIV-1 proviral DNA excision using an evolved recombinase.
Sarkar I; Hauber I; Hauber J; Buchholz F
Science; 2007 Jun; 316(5833):1912-5. PubMed ID: 17600219
[TBL] [Abstract][Full Text] [Related]
7. Impairment of Moloney murine leukemia virus integration in a cell line underexpressing DNA topoisomerase II.
Bouillé P; Subra F; Goulaouic H; Carteau S; Auclair C
Cancer Res; 1995 Jul; 55(14):3211-7. PubMed ID: 7606743
[TBL] [Abstract][Full Text] [Related]
8. Efficient and specific internal cleavage of a retroviral palindromic DNA sequence by tetrameric HIV-1 integrase.
Delelis O; Parissi V; Leh H; Mbemba G; Petit C; Sonigo P; Deprez E; Mouscadet JF
PLoS One; 2007 Jul; 2(7):e608. PubMed ID: 17622353
[TBL] [Abstract][Full Text] [Related]
9. Specific interactions between HIV-1 nucleocapsid protein and the TAR element.
Kanevsky I; Chaminade F; Ficheux D; Moumen A; Gorelick R; Negroni M; Darlix JL; Fossé P
J Mol Biol; 2005 May; 348(5):1059-77. PubMed ID: 15854644
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of the basal-level activity of HIV-1 long terminal repeat by HIV-1 nucleocapsid protein.
Zhang JL; Sharma PL; Crumpacker CS
Virology; 2000 Mar; 268(2):251-63. PubMed ID: 10704334
[TBL] [Abstract][Full Text] [Related]
11. Double-stranded strong-stop DNA and the second template switch in human immunodeficiency virus (HIV) DNA synthesis.
Li P; Stephenson AJ; Kuiper LJ; Burrell CJ
Virology; 1993 May; 194(1):82-8. PubMed ID: 8480430
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication.
McAllister JJ; Phillips D; Millhouse S; Conner J; Hogan T; Ross HL; Wigdahl B
Virology; 2000 Sep; 274(2):262-77. PubMed ID: 10964770
[TBL] [Abstract][Full Text] [Related]
13. Role of glucocorticoid receptor binding sites in the human immunodeficiency virus type 1 long terminal repeat in steroid-mediated suppression of HIV gene expression.
Mitra D; Sikder SK; Laurence J
Virology; 1995 Dec; 214(2):512-21. PubMed ID: 8553553
[TBL] [Abstract][Full Text] [Related]
14. DNA topoisomerases I & II cleavage sites in the type 1 human immunodeficiency virus (HIV-1) DNA promoter region.
Pommier Y; Poddevin B; Gupta M; Jenkins J
Biochem Biophys Res Commun; 1994 Dec; 205(3):1601-9. PubMed ID: 7811242
[TBL] [Abstract][Full Text] [Related]
15. Sequence elements downstream of the human immunodeficiency virus type 1 long terminal repeat are required for efficient viral gene transcription.
Liang C; Li X; Quan Y; Laughrea M; Kleiman L; Hiscott J; Wainberg MA
J Mol Biol; 1997 Sep; 272(2):167-77. PubMed ID: 9299345
[TBL] [Abstract][Full Text] [Related]
16. Effect of topoisomerase inhibitors on the in vitro HIV DNA integration reaction.
Carteau S; Mouscadet JF; Goulaouic H; Subra F; Auclair C
Biochem Biophys Res Commun; 1993 May; 192(3):1409-14. PubMed ID: 8389550
[TBL] [Abstract][Full Text] [Related]
17. Genomic cloning and characterization of the nonoccupied allele corresponding to the integration site of human papillomavirus type 16 DNA in the cervical cancer cell line SiHa.
Bauer-Hofmann R; Borghouts C; Auvinen E; Bourda E; Rösl F; Alonso A
Virology; 1996 Mar; 217(1):33-41. PubMed ID: 8599218
[TBL] [Abstract][Full Text] [Related]
18. Drug-specific sites of topoisomerase II DNA cleavage in Drosophila chromatin: heterogeneous localization and reversibility.
Borgnetto ME; Zunino F; Tinelli S; Kas E; Capranico G
Cancer Res; 1996 Apr; 56(8):1855-62. PubMed ID: 8620504
[TBL] [Abstract][Full Text] [Related]
19. [Interactions of HIV-1 DNA heterocyclic bases with viral DNA].
Agapkina IuIu; Tashlitskiĭ VN; Deprez E; Brochon JC; Shugaliĭ AV; Mouscadet JF; Gottikh MB
Mol Biol (Mosk); 2004; 38(5):848-57. PubMed ID: 15554187
[TBL] [Abstract][Full Text] [Related]
20. Position-specific effects of base mismatch on mammalian topoisomerase II DNA cleaving activity.
Bigioni M; Zunino F; Tinelli S; Austin CA; Willmore E; Capranico G
Biochemistry; 1996 Jan; 35(1):153-9. PubMed ID: 8555169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
